Stelara Now Approved for the Treatment of UC
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The InflammatoryBowelDisease.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Sands BE, Sandborn WJ, Panaccione R, et al. Ustekinumab as induction and maintenance therapy for ulcerative colitis. The New England Journal of Medicine. September 2019; 381, 1201-1214.
- FDA Approves Johnson & Johnson’s Stelara for Ulcerative Colitis. FirstWord Pharma. http://www.firstwordpharma.com/node/1675133#axzz636zgHV87. Published October 21, 2019. Accessed October 24, 2019.
- Janssen Announces U.S. FDA Approval of Stelara (Ustekinumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis. PR Newswire. https://www.prnewswire.com/news-releases/janssen-announces-us-fda-approval-of-stelara-ustekinumab-for-the-treatment-of-adults-with-moderately-to-severely-active-ulcerative-colitis-300941913.html. Published October 21, 2019. Accessed October 24, 2019.